Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer
Background: Enhancing the diagnostic efficacy of early-stage lung cancer is crucial for improving prognosis. The objective of this study was to ascertain dependable exosomal miRNAs as biomarkers for the diagnosis of lung cancer. Methods: Exosomal miRNA candidates were identified through miRNA sequen...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-10-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023082671 |
| _version_ | 1797646465485504512 |
|---|---|
| author | Qian Zhang Kaifu Zheng Yongheng Gao Shihong Zhao Yabo Zhao Wangping Li Yandong Nan Zhengping Li Wei Liu Xinxin Wang Yanwei Chen Gang Liu Faguang Jin |
| author_facet | Qian Zhang Kaifu Zheng Yongheng Gao Shihong Zhao Yabo Zhao Wangping Li Yandong Nan Zhengping Li Wei Liu Xinxin Wang Yanwei Chen Gang Liu Faguang Jin |
| author_sort | Qian Zhang |
| collection | DOAJ |
| description | Background: Enhancing the diagnostic efficacy of early-stage lung cancer is crucial for improving prognosis. The objective of this study was to ascertain dependable exosomal miRNAs as biomarkers for the diagnosis of lung cancer. Methods: Exosomal miRNA candidates were identified through miRNA sequencing and subsequently validated in various case-control sets using real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR). The correlation between the expression of exosomal miRNAs and the clinicopathological features of lung cancer was investigated. To assess the diagnostic efficacy of exosomal miRNAs for lung cancer, the receiver operating characteristic (ROC) curve analysis was conducted. The optimal cutoff value of exosomal miRNAs was determined in the testing cohort and subsequently confirmed in the validation cohort. Results: The results showed that the expression of exosomal miR-1290 was significantly elevated, while that of miR-29c-3p was significantly decreased in the plasma of lung cancer patients, especially in those with early-stage lung cancer, compared to individuals with benign lung conditions (P < 0.01). Exosomal miR-1290 and miR-29c-3p demonstrated superior diagnostic efficacy compared to conventional tumor biomarkers in distinguishing between lung cancer and benign lung diseases, as evidenced by their respective area under the curve (AUC) values of 0.934 and 0.868. Furthermore, exosomal miR-1290 and miR-29c-3p exhibited higher diagnostic efficiency in early-stage lung cancer than traditional tumor markers, with AUC values of 0.947 and 0.895, respectively. Notably, both exosomal miR-1290 and miR-29c-3p displayed substantial discriminatory capacity in distinguishing between non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), as indicated by their respective AUC values of 0.810 and 0.842. Conclusions: The findings of this study provided evidence that exosomal miR-1290 and miR-29c-3p hold significant potential as biomarkers for the early detection of lung cancer, as well as for differentiating between NSCLC and SCLC. |
| first_indexed | 2024-03-11T15:01:59Z |
| format | Article |
| id | doaj.art-a0783a6ad0d646979b34ce6b1120f2f3 |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-03-11T15:01:59Z |
| publishDate | 2023-10-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-a0783a6ad0d646979b34ce6b1120f2f32023-10-30T06:08:15ZengElsevierHeliyon2405-84402023-10-01910e21059Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancerQian Zhang0Kaifu Zheng1Yongheng Gao2Shihong Zhao3Yabo Zhao4Wangping Li5Yandong Nan6Zhengping Li7Wei Liu8Xinxin Wang9Yanwei Chen10Gang Liu11Faguang Jin12Department of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038, China; Department of Respiration, Eastern Air Force Hospital, NanJing 210000, ChinaDepartment of General Surgery, the 991th Hospital of Joint Logistic Support Force of People's Liberation Army, Xiangyang 441000, ChinaDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038, ChinaDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038, ChinaDepartment of Thoracic surgery, Tangdu Hospital, Air Force Military Medical University, Xi'an, ChinaDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038, ChinaDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038, ChinaDepartment of General Surgery, the 991th Hospital of Joint Logistic Support Force of People's Liberation Army, Xiangyang 441000, ChinaDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038, ChinaDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038, ChinaDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038, China; Corresponding authorDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038, China; Corresponding authorDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038, China; Corresponding author.Background: Enhancing the diagnostic efficacy of early-stage lung cancer is crucial for improving prognosis. The objective of this study was to ascertain dependable exosomal miRNAs as biomarkers for the diagnosis of lung cancer. Methods: Exosomal miRNA candidates were identified through miRNA sequencing and subsequently validated in various case-control sets using real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR). The correlation between the expression of exosomal miRNAs and the clinicopathological features of lung cancer was investigated. To assess the diagnostic efficacy of exosomal miRNAs for lung cancer, the receiver operating characteristic (ROC) curve analysis was conducted. The optimal cutoff value of exosomal miRNAs was determined in the testing cohort and subsequently confirmed in the validation cohort. Results: The results showed that the expression of exosomal miR-1290 was significantly elevated, while that of miR-29c-3p was significantly decreased in the plasma of lung cancer patients, especially in those with early-stage lung cancer, compared to individuals with benign lung conditions (P < 0.01). Exosomal miR-1290 and miR-29c-3p demonstrated superior diagnostic efficacy compared to conventional tumor biomarkers in distinguishing between lung cancer and benign lung diseases, as evidenced by their respective area under the curve (AUC) values of 0.934 and 0.868. Furthermore, exosomal miR-1290 and miR-29c-3p exhibited higher diagnostic efficiency in early-stage lung cancer than traditional tumor markers, with AUC values of 0.947 and 0.895, respectively. Notably, both exosomal miR-1290 and miR-29c-3p displayed substantial discriminatory capacity in distinguishing between non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), as indicated by their respective AUC values of 0.810 and 0.842. Conclusions: The findings of this study provided evidence that exosomal miR-1290 and miR-29c-3p hold significant potential as biomarkers for the early detection of lung cancer, as well as for differentiating between NSCLC and SCLC.http://www.sciencedirect.com/science/article/pii/S2405844023082671DiagnosisExosomeLung NeoplasmsMiR-1290MiR-29c-3p |
| spellingShingle | Qian Zhang Kaifu Zheng Yongheng Gao Shihong Zhao Yabo Zhao Wangping Li Yandong Nan Zhengping Li Wei Liu Xinxin Wang Yanwei Chen Gang Liu Faguang Jin Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer Heliyon Diagnosis Exosome Lung Neoplasms MiR-1290 MiR-29c-3p |
| title | Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer |
| title_full | Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer |
| title_fullStr | Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer |
| title_full_unstemmed | Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer |
| title_short | Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer |
| title_sort | plasma exosomal mir 1290 and mir 29c 3p as diagnostic biomarkers for lung cancer |
| topic | Diagnosis Exosome Lung Neoplasms MiR-1290 MiR-29c-3p |
| url | http://www.sciencedirect.com/science/article/pii/S2405844023082671 |
| work_keys_str_mv | AT qianzhang plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT kaifuzheng plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT yonghenggao plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT shihongzhao plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT yabozhao plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT wangpingli plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT yandongnan plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT zhengpingli plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT weiliu plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT xinxinwang plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT yanweichen plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT gangliu plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer AT faguangjin plasmaexosomalmir1290andmir29c3pasdiagnosticbiomarkersforlungcancer |